Dr. Yehia Mohamed is an Associate Professor of Immunology and Infectious Diseases. He completed his undergraduate studies at Al-Azhar University in Cairo, Egypt, and earned his PhD from the Department of Infection, Immunity, and Inflammation at Leicester University Medical School, UK. Dr. Yehia furthered his expertise as a postdoctoral fellow (PDF) at the Jenner Institute, University of Oxford, where he worked as a senior immunology scientist, focusing on monitoring the cellular immune responses in HIV vaccine clinical trials.
With a broad academic background, Dr. Yehia has taught in multiple regions, including the Middle East, Europe, and North America. His academic mission has centered on curriculum development, course coordination, student mentoring, and community service.
Dr. Yehia’s research interests span several key areas within immunology and infectious diseases, including the development of vaccines for chronic respiratory diseases and retroviruses, immunotherapy for tumors, the immunomodulating effects of new medications, and the discovery of natural bioremedies with antimicrobial and antitumor properties.
Dr. Yehia Mohamed is an Associate Professor of Immunology and Infectious Diseases. He completed his undergraduate studies at Al-Azhar University in Cairo, Egypt, and earned his PhD from the Department of Infection, Immunity, and Inflammation at Leicester University Medical School, UK. Dr. Yehia furthered his expertise as a postdoctoral fellow (PDF) at the Jenner Institute, University of Oxford, where he worked as a senior immunology scientist, focusing on monitoring the cellular immune responses in HIV vaccine clinical trials.
With a broad academic background, Dr. Yehia has taught in multiple regions, including the Middle East, Europe, and North America. His academic mission has centered on curriculum development, course coordination, student mentoring, and community service.
Dr. Yehia’s research interests span several key areas within immunology and infectious diseases, including the development of vaccines for chronic respiratory diseases and retroviruses, immunotherapy for tumors, the immunomodulating effects of new medications, and the discovery of natural bioremedies with antimicrobial and antitumor properties.